☰

Landon J. Inge, Ph.D. - Publications

Affiliations: 
2007 University of California, Los Angeles, Los Angeles, CA 
Area:
Cell Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 El-Khoury V, Schritz A, Kim SY, Lesur A, Sertamo K, Bernardin F, Petritis K, Pirrotte P, Selinsky C, Whiteaker JR, Zhang H, Kennedy JJ, Lin C, Lee LW, Yan P, ... ... Inge LJ, et al. Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection. Cancers. 12. PMID 32575471 DOI: 10.3390/Cancers12061629  0.315
2018 Roos A, Dhruv HD, Peng S, Inge LJ, Tuncali S, Pineda M, Millard N, Mayo Z, Eschbacher JM, Loftus JC, Winkles JA, Tran NL. EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival. Molecular Cancer Research : McR. PMID 29724813 DOI: 10.1158/1541-7786.Mcr-18-0125  0.411
2017 Whitsett TG, Mittal SK, Eschbacher JM, Carson VM, Smith MA, Bremner RM, Inge LJ. LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation. The Journal of Thoracic and Cardiovascular Surgery. PMID 29370903 DOI: 10.1016/J.Jtcvs.2017.11.067  0.356
2017 Richer AL, Cala JM, O'Brien K, Carson VM, Inge LJ, Whitsett TG. WEE1 kinase inhibitor AZD1775 has pre-clinical efficacy in LKB1-deficient non-small cell lung cancer. Cancer Research. PMID 28652249 DOI: 10.1158/0008-5472.Can-16-3565  0.368
2017 Roos A, Dhruv HD, Mathews IT, Inge LJ, Tuncali S, Hartman LK, Chow D, Millard N, Yin HH, Kloss J, Loftus JC, Winkles JA, Berens ME, Tran NL. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Oncotarget. PMID 28103571 DOI: 10.18632/Oncotarget.14685  0.376
2016 Richer AL, Cala JM, O’Brien K, Carson VM, Whitsett TG, Inge LJ. Abstract 2817: An inhibitor to the WEE1 kinase has pre-clinical activity in mutant KRAS/LKB1-deficient non-small cell lung cancer Cancer Research. 76: 2817-2817. DOI: 10.1158/1538-7445.Am2016-2817  0.393
2016 Carson VM, Kim S, Inge LJ, Whitsett TG. Abstract 1253: Inhibition of FN14 to suppress KRAS-driven lung cancer migration and survival Cancer Research. 76: 1253-1253. DOI: 10.1158/1538-7445.Am2016-1253  0.424
2015 Patil PU, D'Ambrosio J, Inge LJ, Mason RW, Rajasekaran AK. Carcinoma cells induce lumen filling and EMT in epithelial cells through soluble E-cadherin-mediated activation of EGFR. Journal of Cell Science. 128: 4366-79. PMID 26483386 DOI: 10.1242/Jcs.173518  0.669
2015 Richer AL, Friel JM, Carson VM, Inge LJ, Whitsett TG. Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR. Pharmacogenomics and Personalized Medicine. 8: 63-79. PMID 25897257 DOI: 10.2147/Pgpm.S52845  0.372
2014 Inge LJ, Fowler AJ, Bremner RM. An immunofluorescent method for characterization of Barrett's esophagus cells. Journal of Visualized Experiments : Jove. PMID 25079877 DOI: 10.3791/51741  0.339
2014 Inge LJ, Friel JM, Richer AL, Fowler AJ, Whitsett T, Smith MA, Tran NL, Bremner RM. LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress. Cancer Letters. 352: 187-95. PMID 25011082 DOI: 10.1016/J.Canlet.2014.06.011  0.38
2014 Whitsett TG, Fortin Ensign SP, Dhruv HD, Inge LJ, Kurywchak P, Wolf KK, LoBello J, Kingsley CB, Allen JW, Weiss GJ, Tran NL. FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion. Clinical & Experimental Metastasis. 31: 613-23. PMID 24710956 DOI: 10.1007/S10585-014-9653-6  0.418
2014 David JM, Owens TA, Inge LJ, Bremner RM, Rajasekaran AK. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma. Molecular Cancer Therapeutics. 13: 788-99. PMID 24493697 DOI: 10.1158/1535-7163.Mct-13-0891  0.647
2014 Inge LJ, Friel JM, Fowler A, Richer A, Whitsett T, Tran NL, Bremner RM. Abstract 5470: LKB1 loss sensitizes non-small cell lung cancer cells to aggravation of ER stress Cancer Research. 74: 5470-5470. DOI: 10.1158/1538-7445.Am2014-5470  0.412
2013 Whitsett TG, Inge LJ, Tran NL. The use of quantitative proteomics towards biomarker discovery in lung squamous cell carcinoma. Translational Lung Cancer Research. 2: 457-60. PMID 25806270 DOI: 10.3978/J.Issn.2218-6751.2013.10.17  0.342
2013 Whitsett TG, Inge LJ, Dhruv HD, Cheung PY, Weiss GJ, Bremner RM, Winkles JA, Tran NL. Molecular determinants of lung cancer metastasis to the central nervous system. Translational Lung Cancer Research. 2: 273-83. PMID 25806243 DOI: 10.3978/J.Issn.2218-6751.2013.03.12  0.341
2013 Inge LJ, Fowler AJ, Paquette KM, Richer AL, Tran N, Bremner RM. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia. The Journal of Thoracic and Cardiovascular Surgery. 145: 531-8. PMID 23142123 DOI: 10.1016/J.Jtcvs.2012.10.041  0.353
2012 Barwe SP, Skay A, McSpadden R, Huynh TP, Langhans SA, Inge LJ, Rajasekaran AK. Na,K-ATPase β-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells. Journal of Cell Science. 125: 5711-20. PMID 23077177 DOI: 10.1242/Jcs.108795  0.633
2012 Whitsett TG, Cheng E, Inge L, Asrani K, Jameson NM, Hostetter G, Weiss GJ, Kingsley CB, Loftus JC, Bremner R, Tran NL, Winkles JA. Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion. The American Journal of Pathology. 181: 111-20. PMID 22634180 DOI: 10.1016/J.Ajpath.2012.03.026  0.41
2012 Whitsett TG, Sinari S, Sheff KW, Cheung PY, Ross J, Armstrong B, Inge L, Bremner R, Selinsky C, Betsou F, Phillips R, Cherni I, Trent JM, Von Hoff DD, Carpten JD, et al. Abstract A43: Identification of key tumorigenic pathways in never-smoker lung adenocarcinoma patients using massively parallel DNA and RNA sequencing Clinical Cancer Research. 18: A43-A43. DOI: 10.1158/1078-0432.12Aacriaslc-A43  0.35
2011 Inge LJ, Barwe SP, D'Ambrosio J, Gopal J, Lu K, Ryazantsev S, Rajasekaran SA, Rajasekaran AK. Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Experimental Cell Research. 317: 838-48. PMID 21211535 DOI: 10.1016/J.Yexcr.2010.12.025  0.647
2011 Felton VM, Inge LJ, Willis BC, Bremner RM, Smith MA. Immunosuppression-induced bronchial epithelial-mesenchymal transition: A potential contributor to obliterative bronchiolitis Journal of Thoracic and Cardiovascular Surgery. 141: 523-530. PMID 21163500 DOI: 10.1016/J.Jtcvs.2010.10.006  0.397
2011 Tran NL, Asrani K, Jameson N, Inge L, Cheng E, Hostetter G, Weiss G, Tuncali S, Bremner R, Winkles JA. Abstract 1216: The Fn14 receptor is highly expressed in NSCLC tumors and in NSCLC cell lines harboring EGFR-activating mutations Cancer Research. 71: 1216-1216. DOI: 10.1158/1538-7445.Am2011-1216  0.404
2010 Rajasekaran SA, Huynh TP, Wolle DG, Espineda CE, Inge LJ, Skay A, Lassman C, Nicholas SB, Harper JF, Reeves AE, Ahmed MM, Leatherman JM, Mullin JM, Rajasekaran AK. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Molecular Cancer Therapeutics. 9: 1515-24. PMID 20501797 DOI: 10.1158/1535-7163.Mct-09-0832  0.646
2009 Barwe SP, Jordan MC, Skay A, Inge L, Rajasekaran SA, Wolle D, Johnson CL, Neco P, Fang K, Rozengurt N, Goldhaber JI, Roos KP, Rajasekaran AK. Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit. Journal of Molecular and Cellular Cardiology. 47: 552-60. PMID 19683723 DOI: 10.1016/J.Yjmcc.2009.07.018  0.647
2009 Inge LJ, Coon KD, Smith MA, Bremner RM. Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose Journal of Thoracic and Cardiovascular Surgery. 137: 580-586. PMID 19258070 DOI: 10.1016/J.Jtcvs.2008.11.029  0.437
2008 Inge LJ, Rajasekaran SA, Wolle D, Barwe SP, Ryazantsev S, Ewing CM, Isaacs WB, Rajasekaran AK. alpha-Catenin overrides Src-dependent activation of beta-catenin oncogenic signaling. Molecular Cancer Therapeutics. 7: 1386-97. PMID 18566211 DOI: 10.1158/1535-7163.Mct-07-2029  0.659
2008 Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Mao J, Sharma S, Inge L, Rajasekaran A, Dubinett SM. Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 3: 117-24. PMID 18303430 DOI: 10.1097/Jto.0B013E3181622Bef  0.65
2008 Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, Rajasekaran AK. Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit. Histology and Histopathology. 23: 459-67. PMID 18228203 DOI: 10.14670/Hh-23.459  0.709
2007 Reckamp KL, Gardner BK, Elashoff D, Figlin RA, Krysan K, Dohadwala M, Inge L, Rajasekaran A, Dubinett SM. P3-033: Serum biomarkers predict response to combination celecoxib and erlotinib therapy in advanced non-small cell lung cancer Journal of Thoracic Oncology. 2: S621. DOI: 10.1097/01.Jto.0000283790.42985.55  0.61
2005 Christiansen JJ, Rajasekaran SA, Inge L, Cheng L, Anilkumar G, Bander NH, Rajasekaran AK. N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Molecular Cancer Therapeutics. 4: 704-14. PMID 15897234 DOI: 10.1158/1535-7163.Mct-04-0171  0.692
2003 Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Research. 63: 3145-53. PMID 12810642  0.336
Show low-probability matches.